Chinese Stocks To Follow Now – March 11th

Charming Medical, Diageo, UP Fintech, Regencell Bioscience, and Baiya International Group are the five Chinese stocks to watch today, according to MarketBeat’s stock screener tool. Chinese stocks are equity securities issued by companies that are headquartered in or primarily operate in the People’s Republic of China, and they can trade on domestic exchanges (Shanghai, Shenzhen, STAR Market), in Hong Kong, or overseas as ADRs/ADSs. For investors, they represent a way to gain exposure to China’s economy and growth sectors but also carry specific risks—regulatory and political intervention, accounting and governance differences, currency fluctuations, and varying liquidity—relative to developed-market stocks. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Charming Medical (MCTA)

We are a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. We offer a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Baiya International Group (BIYA)

We, Baiya International Group Inc. (“Baiya”), are an offshore holding company incorporated in the Cayman Islands. We are not a Chinese operating company, but an offshore holding company incorporated in the Cayman Islands. As a holding company, we have no material operations and conduct all of our operations in China through the VIE, Shenzhen Gongwuyuan Network Technology Co., Ltd.